Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
23Andme Holding Co.
(NQ:
ME
)
0.3883
+0.0193 (+5.23%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about 23Andme Holding Co.
< Previous
1
2
3
4
5
6
7
8
9
Next >
23andMe to Report FY2023 First Quarter Financial Results
July 25, 2022
From
23andMe Holding Co.
Via
GlobeNewswire
Jim Cramer Is Shocked This Stock Is At $2: 'I Think That The Risk Is Priced In'
July 12, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he is shocked to see 23andMe Holding Co. (NASDAQ: ME) at $2. "At $2, I think that the risk is priced in," he added.
Via
Benzinga
Worst Performing SPACs: Are They Dead or Will They Rebound?
July 03, 2022
Here are 20 SPACs with truly dreadful performance.
Via
Talk Markets
7 Undervalued Reddit Stocks to Buy Before Wall Street Catches On
June 30, 2022
Reddit stocks had a bad name once, but over time, Reddit has become a more reliable bellwether for stocks to buy in the short term.
Via
InvestorPlace
Earnings Scheduled For February 10, 2022
February 10, 2022
Companies Reporting Before The Bell • Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million.
Via
Benzinga
20 Stocks Moving in Tuesday's Pre-Market Session
June 14, 2022
Gainers Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) rose 48.5% to $2.57 in pre-market trading after the company reached an agreement with Phillip Morris for international electronic nicotine...
Via
Benzinga
Here's What Cramer Has To Say About Zuora, Johnson Controls International And More
June 13, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Zuora Inc (NYSE: ZUO) is losing money. "It does not fit our criteria of what you should own," he added.
Via
Benzinga
Cramer Says This Stock Is 'Way Too Speculative'
April 04, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said 23andMe Holding Co. (NASDAQ: ME) is losing money. "To me, buy it and put it away," he commented.
Via
Benzinga
These 5 SPACs All Plummeted After Celebrities Backed Them
February 28, 2022
Attaching a celebrity's name to a SPAC is a good way to get people excited, but these SPACs all failed despite the support of some big names.
Via
InvestorPlace
Earnings Scheduled For May 26, 2022
May 26, 2022
Companies Reporting Before The Bell • American Woodmark (NASDAQ:AMWD) is likely to report quarterly earnings at $1.34 per share on revenue of $493.20 million.
Via
Benzinga
Florida Credit Firm Leading Credit Repair Firm in all 50 states.
February 25, 2022
5 reasons why we are Rated #1 Credit Repair Firm in the United States. Helping Clients all over the 50 states fixing their credit.
Via
IssueWire
7 Badly Bruised Stocks to Buy for the Tough-as-Nails Contrarian
February 11, 2022
If you loathe groupthink in your investment decisions, these ideas could possibly suit you.
Via
InvestorPlace
23andMe's Q3 Topline Beat Estimates On Boost From Telehealth Business Acquisition
February 11, 2022
23andMe Holding Co (NASDAQ: ME) has updated its FY22 guidance following the inclusion of telehealth operations into its consumer business.
Via
Benzinga
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
February 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
7 Penny Stocks With the Biggest Chance of Blasting Off This Year
February 03, 2022
Penny stocks can rise quickly on relatively small catalysts, making them a great gamble. Here are a few that should rise.
Via
InvestorPlace
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...
Via
Benzinga
Why Jim Cramer Like NextEra Energy And Lincoln Electric?
January 21, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said NextEra Energy, Inc. (NYSE:
Via
Benzinga
23andMe Pivoting To Clinical Research: Could That Lead To A Turnaround For The Stock?
January 18, 2022
Genetic testing company 23andMe Holding Co. (NASDAQ: ME) took the unconventional route of a SPAC deal to go public, and the stock hasn't gained much traction since it began...
Via
Benzinga
7 of The Best SPAC Stocks to Put on Your 2022 Watchlist
December 23, 2021
SPAC stocks may still be out of favor, but you'll still want to keep an eye on these seven picks with merger deals pending.
Via
InvestorPlace
Like Strong Balance Sheets? These 3 Stocks Are Loaded With Cash
December 10, 2021
With these kinds of resources, these companies are becoming less-risky investments.
Via
The Motley Fool
Why 23andMe Stock Dropped 29% in November
December 03, 2021
The company reported disappointing earnings results and has fallen victim to the recent sell-off in high-growth stocks.
Via
The Motley Fool
Why 23andMe Stock Crashed 10% Today
November 15, 2021
Last week's good news for the genetic data miner wasn't as good as it looked.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 15, 2021
November 15, 2021
Upgrades For Targa Resources Corp (NYSE:
Via
Benzinga
Why 23andMe Stock Scored an 11% Gain Today
November 11, 2021
23andMe lost a lot less money than feared today -- so why is it sticking with a prediction for a full-sized loss for the year?
Via
The Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
November 11, 2021
Gainers Liquidia (NASDAQ:LQDA) stock inc...
Via
Benzinga
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
November 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...
Via
Benzinga
Exposures
COVID-19
Kevin Durant Launching A SPAC That Could Target Sports Or Cryptocurrency
November 03, 2021
One of the biggest National Basketball Association stars is dipping his toes into the SPAC market, becoming the latest celebrity or athlete to atta...
Via
Benzinga
Why 23andMe Rocketed 27.9% Higher in October
November 02, 2021
The genetics upstart is acquiring a telehealth platform.
Via
The Motley Fool
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...
Via
Benzinga
November SPAC Merger Calendar: Upcoming Votes, Earnings, Stocks To Watch
November 01, 2021
The month of November shows a continued slowdown in SPAC merger deal votes, but the calendar includes several multibillion-dollar deals. SPAC merger votes can act as a catalyst,...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.